Arterial hypertension
4 papers4 findings
- Humans2
Associations
4Ultra-processed foods
upin humans1
1 study
Ultra-processed foods
upin humans1
Ultra-processed foods are associated with arterial hypertension in humans.
“A positive association was found between the consumption of ultra-processed foods and blood pressure/arterial hypertension”
Review
Nutrients13 Mar 2022
A body shape index
upin humans1
1 study
A body shape index
upin humans1
A body shape index is associated with arterial hypertension in humans.
“When adjusted for BMI, ABSI showed a greater strength of association with the outcomes, but it was not superior to the performance of WC and WHtR.”
Humanswhen adjusted for BMI
Cadernos de saude publica12 Aug 2019
Body mass index
upin humans1
1 study
Body mass index
upin humans1
Body mass index is associated with arterial hypertension in humans.
“results of this study evidenced a higher strength of association between the report of arterial hypertension and diabetes mellitus with BMI, WC and WHtR in the Brazilian population of older adults in separate analyses”
Humansin separate analyses
Cadernos de saude publica12 Aug 2019
Leukoaraiosis
upin humans1
1 study
Leukoaraiosis
upin humans1
Arterial hypertension raises the risk of leukoaraiosis in humans.
“Risk factors for ischemic leukoaraiosis include arterial hypertension, a history of stroke, and age.”
Reviewischemic leukoaraiosiscerebral white matter
Leukoaraiosis and vascular dementia
Neurology1 Sep 1998
Trial sponsors
Company1 trialPhase 3179 people
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Company1 trialPhase 350 people
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Company1 trialPhase 350 people
Company1 trialPhase 1/224 people
1 trialPhase 4200 people
University of Roma La Sapienza
1 trialPhase 4112 people
1 trialPhase 3119 people
Funding
3 grants since 2023National Heart, Lung, and Blood InstituteUS$3.6m
1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
National Heart, Lung, and Blood InstituteCleveland Clinic Lerner Com-cwruUS$873.9k2024–2030
National Heart, Lung, and Blood InstituteVanderbilt University Medical CenterUS$804.8k2022–2027
1/2 Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
National Heart, Lung, and Blood InstituteCleveland Clinic Lerner Com-cwruUS$433.1k2024–2025